Prosecution Insights
Last updated: July 05, 2026

Examiner: WILLKEEN, GREGORY ALAN

Tech Center 1700 • Art Units: 1651 1656 1732

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-65.0% vs TC avg
11
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
14.3%
§102 Novelty
50.0%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18719160 PROBIOTIC COMPOSITIONS AND THEIR USE IN MODULATING ALLERGY-TYPE INFLAMMATORY ACTIVITY Non-Final OA SYNBALANCE SRL
18609015 Multi-strain probiotic formulation for ameliorating or preventing symptoms of treatment resistant depression Non-Final OA Unique Biotech Limited
18588000 WEIGHT LOSS SYNBIOTIC AND PREPARATION METHOD AND USE THEREOF Non-Final OA Renhe Global (Shanghai) Grand Health Research Institute Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month